Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Allergan, Inc.    AGN   US0184901025

ALLERGAN, INC. (AGN)

24
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Allergan, Inc. : Allergan : Studies Show Botox Treats Overactive Bladder

03/28/2012 | 09:54am US/Eastern
Recommend:
0

Allergan Inc. (AGN) filed applications with U.S. and European regulators for approval to sell Botox as a treatment for overactive bladder as two Phase III clinical trials showed the injectible neurotoxin significantly reduced urinary incontinence when compared with a placebo.

Botox is approved for both cosmetic use, such as fighting wrinkles, and for various medical issues, including urinary incontinence in patients with neurologic conditions such as spinal-cord injury and multiple sclerosis.

Allergan on Wednesday said Botox met the primary endpoints of significantly reducing urinary incontinence, or bladder leakage, episodes in patients who have an inadequate response to or are intolerant of an anticholinergic medication.

Based on the results, Allergan has submitted a supplemental biologics license application with the U.S. Food and Drug Administration and an application with European Regulatory authorities to approve the use of Botox by adult patients not managed by an anticholinergic treatment.

The drug maker has been expanding its pipeline of late, such as buying Vicept Therapeutics Inc., the developer of a cream to treat rosacea, and striking a deal with Map Pharmaceuticals Inc. (MAPP) to jointly promote Map's experimental migraine treatment Levadex.

Allergan reported last month its fourth-quarter earnings rose 6.3% as higher specialty pharmaceuticals sales contributed to a 7.1% revenue jump.

-By Melodie Warner, Dow Jones Newswires; 212-416-2283; melodie.warner@dowjones.com

Recommend :
0
React to this article
Latest news on ALLERGAN, INC.
2h ago ALLERGAN : Affirms Receipt of Unsolicited Proposal from Valeant
2h ago ALLERGAN : Discloses Public Filings by Valeant and Pershing Square for Proposed ..
1d ago EXCLUSIVE - ALLERGAN APPROACHED SHIR : sources
1d agoDJSizable Allergan Investor Doesn't Favor Valeant Offer -- Update
1d ago ALLERGAN : Bill Ackman Has Big Plans
1d agoDJU.S. Stocks Rise, Buoyed by Apple Results
1d ago Zimmer to buy Biomet for $13.35 billion in latest consolidation
1d agoDJStocks Open Higher; Apple Rallies
2d ago ALLERGAN : Bill Ackman’s Got A Fever And The Only Prescription Is More Tak..
2d ago ALLERGAN : Patent Issued for Processes for Making Porous Implantable Materials
Advertisement
Chart
Duration : Period :
Allergan, Inc. Technical Analysis Chart | AGN | US0184901025 | 4-Traders
Income Statement Evolution
Allergan, Inc. : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF